Balaji Amines Limited (BALAMINES) Price & Analysis

Compare

4 Followers

BALAMINES Stock Chart & Stats

₹1090.80

₹185.05(10.63%)

At close: Jan 09 4:00 PM EST

₹1090.80

₹185.05(10.63%)

Day’s Range― - ―

52-Week Range₹905.15 - ₹1,946.00

Previous CloseN/A

Volume2.22M

Average Volume (3M)3.13K

Market Cap

₹34.75B

Enterprise Value₹33.76B

Total Cash (Recent Filing)₹3.50B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)29.5

Beta1.29

Next Earnings

May 13, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.97%

Share Statistics

EPS (TTM)12.20

Shares Outstanding32,401,000

10 Day Avg. Volume2,179

30 Day Avg. Volume3,132

Financial Highlights & Ratios

PEG Ratio-1.11

Price to Book (P/B)2.20

Price to Sales (P/S)2.91

P/FCF Ratio46.43

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)41.45

Revenue Forecast (FY)₹13.64B

Bulls Say, Bears Say

Bulls Say

Strong Balance SheetA low debt load and robust equity ratio give Balaji Amines durable financial flexibility. Over the next 2-6 months this reduces refinancing risk, preserves capacity to fund working capital through cycles, and supports strategic capital allocation into downstream products.

Positive Free Cash FlowSustained positive free cash flow supports internal funding of maintenance capex and selective expansions without relying heavily on external debt. This enhances the company's ability to invest in higher-value derivatives and maintain operations during cyclical downturns.

Specialty Chemical Franchise & Diversified End-marketsA product mix centered on aliphatic amines and derivatives sold into pharma, agro, water treatment and rubber creates durable demand diversification. Serving both domestic and export customers reduces single-market reliance and supports stable long-term volumes and margin opportunities.

Bears Say

Revenue And Earnings ContractionDeclining revenue and sharply negative EPS growth indicate underlying demand or competitive pressures. If these trends persist beyond a few quarters they can constrain reinvestment, weaken margin resilience, and reduce the room to scale higher‑margin downstream products or reward shareholders.

Exposure To Commodity CyclicalitySignificant exposure to core amine volumes and realized prices ties profitability to raw-material swings and cyclical end-market demand. That structural exposure can compress margins in downturns and makes durable margin expansion dependent on successful downstream integration.

Need For Stronger Cash Flow Growth To Fund ExpansionAlthough FCF is positive, management notes a need to grow cash flow to finance expansion. Without stronger cash flow growth, plans to scale downstream capabilities or invest in higher-value lines may require external financing, slowing strategic progress and raising execution risk.

Balaji Amines Limited News

Balaji Amines Opens Special Window for Transfer and Demat of Physical Shares

Balaji Amines Limited ( ($IN:BALAMINES) ) has shared an announcement. Balaji Amines Limited has announced that it has...

2d ago

Balaji Amines Reschedules Q2FY26 Earnings Call

An update from Balaji Amines Limited ( ($IN:BALAMINES) ) is now available. Balaji Amines Limited has announced a...

4M ago

Balaji Amines Clarifies Misleading Article on Chemical Production

An update from Balaji Amines Limited ( ($IN:BALAMINES) ) is now available. Balaji Amines Limited has issued a...

5M ago

Balaji Amines Limited Submits Compliance Certificate for Q3 2025

Balaji Amines Limited ( ($IN:BALAMINES) ) has provided an announcement. Balaji Amines Limited has submitted a certificate under...

5M ago

Balaji Amines Limited Holds 37th AGM with Transparent E-voting

Balaji Amines Limited ( ($IN:BALAMINES) ) has issued an announcement. Balaji Amines Limited conducted its 37th Annual General...

7M ago

Balaji Amines Schedules Investor Meeting to Discuss Public Information

The latest update is out from Balaji Amines Limited ( ($IN:BALAMINES) ). Balaji Amines Limited has announced that...

12M ago

BALAMINES FAQ

What was Balaji Amines Limited’s price range in the past 12 months?

Balaji Amines Limited lowest stock price was ₹905.15 and its highest was ₹1946.00 in the past 12 months.

What is Balaji Amines Limited’s market cap?

Balaji Amines Limited’s market cap is ₹34.75B.

When is Balaji Amines Limited’s upcoming earnings report date?

Balaji Amines Limited’s upcoming earnings report date is May 13, 2026 which is in 67 days.

How were Balaji Amines Limited’s earnings last quarter?

Balaji Amines Limited released its earnings results on Jan 29, 2026. The company reported ₹12.2 earnings per share for the quarter, the consensus estimate of ₹12.2 by ₹0.

Is Balaji Amines Limited overvalued?

According to Wall Street analysts Balaji Amines Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Balaji Amines Limited pay dividends?

Balaji Amines Limited pays a Annually dividend of ₹11 which represents an annual dividend yield of 0.97%. See more information on Balaji Amines Limited dividends here

What is Balaji Amines Limited’s EPS estimate?

Balaji Amines Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Balaji Amines Limited have?

Balaji Amines Limited has 32,401,000 shares outstanding.

What happened to Balaji Amines Limited’s price movement after its last earnings report?

Balaji Amines Limited reported an EPS of ₹12.2 in its last earnings report, expectations of ₹12.2. Following the earnings report the stock price went down -5.893%.

Which hedge fund is a major shareholder of Balaji Amines Limited?

Currently, no hedge funds are holding shares in IN:BALAMINES

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Balaji Amines Limited

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates through three segments: Amines & Speciality Chemicals, Hotel, and CFL Lamps. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, and acetonitrile. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, and choline chloride; and pharma excipients, such as poly vinyl pyrrolidone. It serves pharmaceutical, agrochemical, paint and resin, animal feed, oil and gas, rubber cleaning chemical, dye and textile, and water treatment chemical industries. In addition, the company operates Balaji Sarovar, a hotel in Solapur, Maharashtra; and manufactures and sells CFL lamps. It also exports its products to the United States, Europe, China, Turkey, Korea, Malaysia, Kuwait, and internationally. The company was incorporated in 1988 and is based in Hyderabad, India.